
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group reported a total revenue of $1,649 million for the quarter, marking an approximate 8.1% year-over-year increase, driven by strong demand in the Market Data segment, which grew by around 14.5% with substantial contributions from both new users and pricing adjustments. The company has shown consistent resilience in its financial performance, demonstrated by robust free cash flow generation that has allowed for increased quarterly dividend payments over 14 consecutive years, highlighting its commitment to returning value to shareholders. Additionally, CME Group has achieved a compound annual growth rate of over 7% in average daily volume (ADV) from FY16 to FY24, showcasing effective customer engagement and continuous product innovation that contributed approximately $254 million in revenue over the past five years.
Bears say
CME Group faces considerable headwinds due to expected declines in trading volume for interest rate futures coupled with pricing pressures and heightened competition, particularly from FMX. The company is forecasting a total revenue growth of approximately 5.4% year-over-year, which is below the market consensus and indicates a potential underperformance against industry expectations. Additionally, increased regulatory scrutiny poses a risk to trading volumes, further complicating the company’s financial outlook and contributing to a cautious sentiment among investors.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares